Peptide wholesale glossary
Updated
This glossary defines the terms that come up when a laboratory, distributor, brand or pharmacy evaluates a peptide supplier. Each definition is general. It explains what the word means in the trade and does not describe any particular lot or product.
Use it alongside the documents you receive. If you are reading a certificate of analysis for the first time, start with what a batch COA should contain, then see how documentation is handled on our quality page. Terms are listed in the order a buyer tends to meet them: identity and purity, production, commercial and supply terms, regulation, then brand services.
For the regulatory entries, the primary sources are the ones to rely on. FDA explains the difference between pharmacy and outsourcing facility compounding on its human drug compounding page, the text of the cGMP rules is in 21 CFR part 211 at eCFR, and the research-use-only labeling rule for diagnostic products is in 21 CFR 809.10(c). Rules change, so confirm the current text before you rely on a definition for a compliance decision.
- COA (certificate of analysis)
- A report of the test results for one specific lot, issued by the laboratory or manufacturer that tested it. It should name the lot, the methods used, the results and the date.
- Lot number (batch number)
- An identifier assigned to a defined quantity of material made in one production run. Records, test results and shipments are tied back to it.
- HPLC (high-performance liquid chromatography)
- A separation technique that passes a dissolved sample through a packed column under pressure so its components elute at different times. In peptide work it is the usual method for reporting chromatographic purity.
- UHPLC (ultra-high-performance liquid chromatography)
- A variant of HPLC that uses smaller column particles and higher pressures. It generally gives faster runs and sharper peaks than conventional HPLC.
- Mass spectrometry (MS)
- An analytical technique that measures the mass-to-charge ratio of ions. For a peptide, it checks whether the measured molecular mass matches the expected value for the sequence.
- LC-MS
- A liquid chromatography system coupled to a mass spectrometer. It reports retention behavior and molecular mass in one run.
- Net peptide content
- The share of the powder's weight that is the peptide itself, as opposed to water, counterions and residual salts. It is usually lower than HPLC purity, because purity ignores water and counterions.
- Purity by HPLC
- The area of the main peak expressed as a percentage of the total peak area in a chromatogram at a set detection wavelength. It describes related impurities seen by that method and does not measure how much of the powder is peptide.
- Counterion
- An ion that balances the charge of the peptide in its solid form. The type and amount of counterion depend on how the peptide was cleaved, purified and isolated.
- TFA salt
- A peptide supplied with trifluoroacetate as its counterion. Trifluoroacetic acid is widely used in synthesis cleavage and in HPLC purification, so this is a common default salt form.
- Acetate salt
- A peptide supplied with acetate as its counterion, usually after an ion-exchange or purification step replaces trifluoroacetate. Buyers sometimes specify it because some cell-based assays are sensitive to trifluoroacetate.
- Water content (Karl Fischer)
- The amount of water in a lyophilized powder, commonly measured by Karl Fischer titration. It is one of the components that makes net peptide content lower than 100 percent.
- Endotoxin testing (LAL)
- A test that detects bacterial endotoxins using limulus amebocyte lysate. Results are reported in endotoxin units per unit of mass or volume, and the test is described in USP chapter 85.
- Residual solvents
- Organic solvents left in a material after manufacturing. Limits and test approaches are set out in ICH Q3C and in USP chapter 467.
- Amino acid analysis
- A method that breaks a peptide into its individual amino acids and measures each one. It is used to check composition and to estimate peptide content.
- Peptide sequence
- The ordered list of amino acids in a peptide, written from the N-terminus to the C-terminus. Identity testing is built around confirming it.
- Molecular weight
- The mass of one mole of a compound, expressed in grams per mole or daltons. Buyers compare it with the mass measured by mass spectrometry.
- CAS number
- A unique numeric identifier assigned by the Chemical Abstracts Service to a specific chemical substance. It helps match one material across suppliers, though not every peptide or salt form has its own entry.
- Impurity profile
- The list of related substances found alongside the main compound, such as truncated or deleted sequences. Chromatographic purity is a summary of it.
- Specification
- The documented set of tests, methods and acceptance limits a lot must meet before release. A COA reports results against it.
- Reference standard
- A well-characterized material used as a comparison point for identity or quantity in an analytical test.
- Solid-phase peptide synthesis (SPPS)
- A method in which a peptide chain is built one amino acid at a time while anchored to an insoluble resin. The finished chain is then cleaved from the resin and purified.
- Lyophilization (freeze-drying)
- Removal of water from a frozen material under vacuum. Most research peptides are supplied as a lyophilized powder because the dry form is generally more stable than a solution.
- Lyophilized powder
- The dry, porous solid that remains after freeze-drying. It often holds some moisture and counterions in addition to the peptide.
- Cold chain
- Temperature-controlled storage and transport from the point of manufacture to the point of receipt. Records usually include temperature set points and, for some shipments, data logger readings.
- MOQ (minimum order quantity)
- The smallest quantity a supplier will accept in one order. It can be set per item, per lot or per order.
- Volume tier
- A band of order quantity that carries its own commercial terms. Each supplier sets its own bands; no standard defines them.
- Lead time
- The time from order confirmation to dispatch or to arrival. Say which one a quote means. Made-to-order items usually have longer lead times than stocked items.
- USA stock
- Inventory held in the US that ships from US inventory. It does not by itself say where the peptide was synthesized.
- Overseas-sourced supply
- Material made outside the US and shipped in. Lead times are longer; typically 7-10 days for this supplier's overseas orders.
- Lot traceability
- The ability to follow a lot from raw materials through production, testing and shipment to a named customer. It depends on records that link each step to the lot number.
- Retained sample
- A portion of a lot kept by the manufacturer, supplier or buyer after release so that it can be retested if a question arises later.
- Certificate of conformance
- A statement from a supplier that a shipment meets stated requirements. Unlike a COA, it does not necessarily report measured results.
- Research use only (RUO)
- A trade labeling convention for research chemicals, meaning the material is sold for laboratory research and not for diagnostic, clinical or consumer use. It is not a regulatory category for research chemicals; its formal regulatory use is for in-vitro diagnostic products under 21 CFR 809.10(c).
- API (active pharmaceutical ingredient)
- The component of a drug product that is responsible for its pharmacological activity. APIs are manufactured and handled under quality systems that differ from those for research materials.
- Section 503A
- The section of the Federal Food, Drug, and Cosmetic Act that covers drug compounding by a licensed pharmacist or physician for an identified individual patient, based on a prescription.
- 503B outsourcing facility
- A facility registered with FDA under section 503B of the Federal Food, Drug, and Cosmetic Act that compounds sterile drugs. It can supply compounded drugs without patient-specific prescriptions and is subject to current good manufacturing practice requirements.
- Bulks list
- FDA's lists of bulk drug substances that may be used in compounding: under 503A, set by rulemaking; under 503B, those with a clinical need. 503A also allows monograph or approved-drug components; 503B also allows drugs on FDA's shortage list.
- cGMP (current good manufacturing practice)
- FDA regulations on the methods, facilities and controls used to make drugs, found for finished pharmaceuticals in 21 CFR parts 210 and 211. The word current signals that expectations evolve.
- ISO/IEC 17025
- An international standard setting general requirements for the competence, impartiality and consistent operation of testing and calibration laboratories. A laboratory can be accredited to it by an accreditation body for the tests on its scope.
- ISO 9001
- An international standard for quality management systems. Certification means a certification body found an organization's management system meets the standard, and it says nothing about any individual product.
- White label
- A product made by one company and sold under another company's brand, usually from the maker's existing formulation or catalog item with a new label.
- Private label
- A product made to a brand owner's own specification and sold only under that brand. It often involves more input on design and packaging than white label.
- Dropshipping
- A fulfillment arrangement in which a supplier ships orders directly to the end customer on behalf of a reseller, so the reseller holds no stock.
- 3PL (third-party logistics)
- An outside company that handles warehousing, picking, packing and shipping for a business.